Treatment of Severe Hypercalcemia Using Continuous Renal Replacement Therapy With Regional Citrate Anticoagulation
- 1 July 2008
- journal article
- case report
- Published by Ovid Technologies (Wolters Kluwer Health) in Asaio Journal
- Vol. 54 (4), 442-444
- https://doi.org/10.1097/mat.0b013e31817dc3be
Abstract
We report a patient with severe hypercalcemia and acute kidney failure, in whom citrate anticoagulation was used not only for anticoagulation but also to correct ionized hypercalcemia (1.77 mmol/L). In this patient, after a complicated surgical procedure, septic shock led to acute kidney failure. We started continuous venovenous hemodialysis with citrate anticoagulation. By almost stopping the calcium substitution during the first hours, elevated systemic ionized calcium decreased into the normal range within 8 hours. Although calcium substitution was then increased, serum ionized calcium decreased to a nadir of 0.86 mmol/L and then stabilized within the normal range within the next 24 hours. To correct the imbalance in systemic ionized calcium concentration, the calcium substitution was varied over a wide range of 0.1-3.0 mmol/L of generated effluent. The time delay between adjustment in calcium infusion rate and the first detectable change in ionized calcium level was below 4 hours. However, the full response to a change of the calcium substitution was found after 8-12 hours.Keywords
This publication has 5 references indexed in Scilit:
- Clinical review: Patency of the circuit in continuous renal replacement therapyCritical Care, 2007
- Metabolic Complications during Regional Citrate Anticoagulation in Continuous Venovenous Hemodialysis: Single-Center ExperienceNephron Clinical Practice, 2004
- Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulationCritical Care Medicine, 2001
- Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantationClinical Biochemistry, 1995
- Regional Citrate Anticoagulation for Hemodialysis in the Patient at High Risk for BleedingNew England Journal of Medicine, 1983